Role of branched-chain amino acids in management of cirrhosis and hepatocellular carcinoma

Hepatology Research

Volumn 38, Issue SUPPL. 1, 2008, Pages

  Lam, Vincent W ^a,b   Poon, Ronnie T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Branched chain amino acids; Cirrhosis; Hepatic encephalopathy; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

ALBUMIN; AMINO ACID DERIVATIVE; AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID; CARBOHYDRATE; CASEIN; GLUCOSE; LACTULOSE; LIPID; MALTODEXTRIN; NEOMYCIN; NITROGEN; PROTEIN DERIVATIVE;

CLINICAL TRIAL; CONFERENCE PAPER; DIET THERAPY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MITOGENESIS; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; UNSPECIFIED SIDE EFFECT;

EID: 58049084242     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00435.x     Document Type: Conference Paper

References (58)

1. Fan ST, Poon RTP. Liver disease and parenteral nutrition. In: Rolandelli RH, Rombeau JL, eds. Clinical Nutrition-Parenteral Nutrition, 3rd edn. Philadephia: WB Saunders, 2001; 392.
2. Kondrup J. Nutrition in end stage liver disease. Baillieres Best Pract Res Clin Gastroenterol 2006; 20: 547-60.
3. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr 2006; 136 (Suppl 1): S295-8.
4. Caregaro L, Alberino F, Amodio P et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 1996; 63: 602-9.
5. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992; 70: 478-86.
6. Muller MJ, Bottcher J, Selberg O et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999; 69: 1194-201.
7. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 202-9.
8. Plauth M, Cabre E, Riggio O et al. Guidelines on enteral nutrition: liver disease. Clin Nutr 2006; 25: 285-94.
9. Merli M, Nicolini G, Angeloni S, Riggio O. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 2002; 18: (11-12): 978-86.
10. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? Hepatology 1996; 23: 1041-6.
11. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-52.
12. Alberino F, Gatta A, Amodio P et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445-50.
13. Choudry HA, Pan M, Karinch AM, Souba WW. Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr 2006; 136 (Suppl 1): S314-18.
14. Marchesini G, Marzocchi R, Noia M, Bianchi G. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 2005; 135 (Suppl 6): S1596-601.
15. Shimomura Y, Honda T, Goto H et al. Effects of liver failure on the enzymes in the branched-chain amino acid catabolic pathway. Biochem Biophys Res Commun 2004; 313: 381-5.
16. Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 2004; 313: 405-9.
17. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: A unified theory of portal-systemic encephalopathy. Lancet 1979; 2: 772-5.
18. Kajiwara K, Okuno M, Kobayashi T et al. Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 1998; 43: 1572-9.
19. De Caterina M, Piccolboni D, Alfieri R et al. Effects of total parenteral nutrition enriched with branched chain amino acid infusion on liver function and serum amino acid pattern in dogs undergoing hepatectomy. Ric Clin Lab 1985; 15: 79-88.
20. Rigotti P, Peters JC, Tranberg KG, Fischer JE. Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat. JPEN J Parenter Enteral Nutr 1986; 10: 17-20.
21. Tomiya T, Inoue Y, Yanase M et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 2002; 297: 1108-11.
22. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526-33.
23. Nakamura I, Ochiai K, Imawari M. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol Res 2004; 29: 207-11.
24. Wang X, Andersson R, Soltesz V, Bengmark S. Bacterial translocation after major hepatectomy in patients and rats. Arch Surg 1992; 127: 1101-6.
25. Ferenci P, Funovics J, Wewalka F. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions]. Chir Forum Exp Klin Forsch 1978; 183-9.
26. Rossi-Fanelli F, Riggio O, Cangiano C et al. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: A controlled study. Dig Dis Sci 1982; 27: 929-35.
27. Wahren J, Denis J, Desurmont P et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 1983; 3: 475-80.
28. Michel H, Bories P, Aubin JP, Pomier-Layrargues G, Bauret P, Bellet-Herman H. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 1985; 5: 282-9.
29. Cerra FB, Cheung NK, Fischer JE et al. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: A prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 1985; 9: 288-95.
30. Fiaccadori F, Ghinelli F, Pedretti G et al. Branched-chain enriched amino acid solutions in the treatment of hepatic encephalopathy: A controlled trial. Ital J Gastroenterol 1985; 17: 5-10.
31. Strauss E, dos Santos WR, da Silva EC, Lacet CM, Capacci MLL, Bernardini AP. Treatment of hepatic encephalopathy: A randomized clinical trial comparing branched chain enriched amino acid solution to oral neomycin. Nutr Supp Serv 1986; 6: 18-21.
32. Vilstrup H, Gluud C, Hardt F et al. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J Hepatol 1990; 10: 291-6.
33. Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: A randomized, prospective trial. [see comment]. Surgery 1988; 104: 482-8.
34. Eriksson LS, Persson A, Wahren J. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy. Gut 1982; 23: 801-6.
35. Sieg A, Walker S, Czygan P et al. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial. Z Gastroenterol 1983; 21: 644-50.
36. Simko V. Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease. Nutr Rep Int 1983; 27: 765-73.
37. McGhee A, Henderson JM, Millikan WJ et al. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg 1983; 197: 288-93.
38. Horst D, Grace ND, Conn HO et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: A randomized controlled trial. Hepatology 1984; 4: 279-87.
39. Guarnieri GF, Toigo R, Situlin R et al. Muscle biopsy study on malnutrition in patients with liver cirrhosis. In: Capocaccia L, Fischer JE, Rossi-Fanelli F, eds. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984; 193-209.
40. Christie ML, Sack DM, Pomposelli J, Horst D. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. JPEN J Parenter Enteral Nutr 1985; 9: 671-8.
41. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 1985; 88: 887-95.
42. Fiaccadori F, Elia GF, Lehndorff H etal. The effect of dietary supplementation with branched-chain amino acids vs. casein in patients with chronic recurrent portal systemic encephalopathy: A controlled trial. In: Advances in Ammonia Metabolism and Hepatic Encephalopathy, Soeters PB, Wilson JHP, Meijer AJ, Holm E, eds. Amsterdam, The Netherlands: Excerpta Medica, 1988.
43. Swart GR, van den Berg WO, van Vuure JK, Rietveld D, Wattimena DL, Frenkel M. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 1989; 8: 329-36.
44. Marchesini G, Dioguardi FS, Bianchi GP et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 1990; 11: 92-101.
45. Marchesini G, Bianchi G, Merli M etal. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial. [see comment]. Gastroenterology 2003; 124: 1792-801.
46. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. [see comment]. Clin Gastroenterol Hepatol 2005; 3: 705-13.
47. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003; (2): CD001939.
48. Fukushima H, Miwa Y, Ida E et al. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: Comparison with daytime administration. JPEN J Parenter Enteral Nutr 2003; 27: 315-22.
49. The San-in Group of Liver Surgery. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: A prospective randomized trial. The San-in Group of Liver Surgery. [see comment]. Br J Surg 1997; 84: 1525-31.
50. Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 1999; 69: 811-15.
51. Poon RTP, Yu WC, Fan ST, Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: A randomized trial. Aliment Pharmacol Ther 2004; 19: 779-88.
52. Fan ST, Lo CM, Liu CL et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229: 322-30.
53. Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003; 17: 401-11.
54. Figueiredo F, Dickson ER, Pasha T etal. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000; 70: 1347-52.
55. Chin SE, Shepherd RW, Thomas BJ et al. Nutritional support in children with end-stage liver disease: A randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992; 56: 158-63.
56. Tietge UJF, Bahr MJ, Manns MP, Boker KHW. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl Int 2003; 16: 1-8.
57. Mager DR, Wykes LJ, Roberts EA, Ball RO, Pencharz PB. Effect of orthotopic liver transplantation (OLT) on branched-chain amino acid requirement. Pediatr Res 2006; 59: 829-34.
58. Reilly J, Mehta R, Teperman L et al. Nutritional support after liver transplantation: A randomized prospective study. [see comment]. JPEN J Parenter Enteral Nutr 1990; 14: 386-91.